Continuous Subcutaneous Insulin Infusion (CSII)

Continuous Subcutaneous Insulin Infusion (CSII), commonly known as Insulin pump therapy, offers a modern way to manage diabetes. It helps maintain blood sugar levels by mimicking the body’s natural Insulin release. CSII is particularly helpful for those requiring precise Insulin control.

Definition

CSII is a method of Insulin delivery where a small pump provides a continuous flow of Insulin through a thin tube inserted under the skin. This device eliminates the need for multiple daily Insulin injections by delivering both basal (constant) and bolus (on-demand) Insulin.

Causes

CSII is not a treatment for the causes of diabetes but rather a delivery method to manage it. It's prescribed for individuals with diabetes who require Insulin therapy but struggle to control glucose levels with injections.

Risk Factors

• The need for intensive Insulin management.
• Frequent episodes of Low blood sugar (Hypoglycemia).
• Unstable blood sugar levels despite multiple Insulin injections.
• High HbA1c levels despite diabetes management efforts.

Symptoms

CSII doesn’t address symptoms directly but helps prevent those linked to poorly managed diabetes, such as:

• Fatigue
• Excessive thirst
• Frequent urination
• Blurred vision

Diagnosis

CSII is typically recommended by healthcare professionals after evaluating the need for enhanced glucose control, a person's willingness to use the device, and overall health.

Management

• Pump Setup: A healthcare provider programs Insulin doses according to the user’s needs.
• Monitoring: Regular glucose testing ensures the pump remains effective.
• Lifestyle Adaptation: Users may adjust pump settings for meals, exercise, and sleep to maintain stable glucose levels.

Additional Notes

CSII can significantly improve quality of life for many people with diabetes. Individuals must stay engaged with care teams to ensure it works optimally for their needs.